The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Proteolytic Cleavage of Human p53 by Calpain: a Potential Regulator of Protein Stability
Open accessAbstract
The p53 tumor suppressor protein is activated in cells in response to DNA damage and prevents the replication of cells sustaining genetic damage by inducing a cell cycle arrest or apoptosis. Activation of p53 is accompanied by stabilization of the protein, resulting in accumulation to high levels within the cell. p53 is normally degraded through the proteasome following ubiquitination, although the mechanisms which regulate this proteolysis in normal cells and how the p53 protein becomes stabilized following DNA damage are not well understood. We show here that p53 can also be a substrate for cleavage by the calcium-activated neutral protease, calpain, and that a preferential site for calpain cleavage exists within the N terminus of the p53 protein. Treatment of cells expressing wild-type p53 with an inhibitor of calpain resulted in the stabilization of the p53 protein. By contrast, in vitro or in vivo degradation mediated by human papillomavirus E6 protein was unaffected by the calpain inhibitor, indicating that the stabilization did not result from inhibition of the proteasome. These results suggest that calpain cleavage plays a role in regulating p53 stability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationRock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
In Vivo Half-Life of a Protein Is a Function of Its Amino-Terminal Residue
Bachmair, A., Finley, D., & Varshavsky, A. (1986) · Science · doi:10.1126/science.3018930 · Cited by 1,971
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Identification of p53 as a Sequence-Specific DNA-Binding Protein
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., & Vogelstein, B. (1991) · Science · doi:10.1126/science.2047879 · Cited by 1,085
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689 · Cited by 893
Database of p53 gene somatic mutations in human tumors and cell lines.
Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 858
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes
Caelles, C., Helmberg, A., & Karin, M. (1994) · Nature · doi:10.1038/370220a0 · Cited by 843
Calcium-activated neutral protease (calpain) system: structure, function, and regulation.
Croall, D. E., & DeMartino, G. N. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.3.813 · Cited by 833
Abnormal Centrosome Amplification in the Absence of p53
Fukasawa, K., Choi, T., Kuriyama, R., Rulong, S., & Woude, G. F. V. (1996) · Science · doi:10.1126/science.271.5256.1744 · Cited by 797
Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.
Fritsche, M., Haessler, C., & Brandner, G. (1993) · PubMed · Cited by 747
A transcriptionally active DNA-binding site for human p53 protein complexes.
Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., & Shay, J. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2866 · Cited by 732
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Lin, J., Chen, J., Elenbaas, B., & Levine, A. J. (1994) · Genes & Development · doi:10.1101/gad.8.10.1235 · Cited by 653
In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki, C. G., Huibregtse, J. M., & Howley, P. M. (1996) · PubMed · Cited by 645
Graeber, T. G., Peterson, J. F., Tsai, M., Monica, K., Fornace, A. J., & Giaccia, A. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6264 · Cited by 614
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
Self-citationWagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 539
Linke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A., & Wahl, G. M. (1996) · Genes & Development · doi:10.1101/gad.10.8.934 · Cited by 538
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., & Cho, K. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3988 · Cited by 526
Crook, T., Vousden, K. H., & Tidy, J. A. (1991) · Cell · doi:10.1016/0092-8674(91)90529-8 · Cited by 505
Self-citationPrimary structure polymorphism at amino acid residue 72 of human p53.
Matlashewski, G. J., Tuck, S., Pim, D., Lamb, P., Schneider, J., & Crawford, L. V. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.961 · Cited by 497
Varshavsky, A. (1992) · Cell · doi:10.1016/0092-8674(92)90285-k · Cited by 467
Induction of cellular p53 activity by DNA-damaging agents and growth arrest.
Zhan, Q., Carrier, F., & Fornace, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4242 · Cited by 441
Small peptides activate the latent sequence-specific DNA binding function of p53
Hupp, T. R., Sparks, A., & Lane, D. P. (1995) · Cell · doi:10.1016/0092-8674(95)90165-5 · Cited by 434
Calpain activation in apoptosis
Squier, M. K. T., Miller, A. C. K., Malkinson, A. M., & Cohen, J. J. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041590206 · Cited by 433
A comparison of the biological activities of wild‐type and mutant p53
Zambetti, G. P., & Levine, A. J. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344485 · Cited by 413
Sequence-specific transcriptional activation is essential for growth suppression by p53.
Pietenpol, J. A., Tokino, T., Thiagalingam, S., el-Deiry, W. S., Kinzler, K. W., & Vogelstein, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.1998 · Cited by 406
mdm-2 Inhibits the G1 Arrest and Apoptosis Functions of the p53 Tumor Suppressor Protein
Chen, J., Wu, X., Lin, J., & Levine, A. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2445 · Cited by 350
p53 in signaling checkpoint arrest or apoptosis
Bates, S., & Vousden, K. H. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90004-0 · Cited by 331
Self-citationIncreased activity of p53 in senescing fibroblasts
Atadja, P., Wong, H., Garkavtsev, I., Veillette, C., & Riabowol, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8348 · Cited by 308
Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway.
Chowdary, D. R., Dermody, J. J., Jha, K. K., & Ozer, H. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1997 · Cited by 278
Unger, T., Nau, M. M., Segal, S., & Minna, J. D. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05183.x · Cited by 261
Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin?
Goll, D. E., Thompson, V. F., Taylor, R. G., & Zalewska, T. (1992) · BioEssays · doi:10.1002/bies.950140810 · Cited by 234
Transcriptional activation by p53 correlates with suppression of growth but not transformation
CROOK, T. (1994) · Cell · doi:10.1016/0092-8674(94)90071-x · Cited by 233
Cell type-specific inhibition of p53-mediated apoptosis by mdm2.
Haupt, Y., Barak, Y., & Oren, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00504.x · Cited by 228
Essential role for p53-mediated transcription in E1A-induced apoptosis.
Sabbatini, P., Lin, J., Levine, A. J., & White, E. (1995) · Genes & Development · doi:10.1101/gad.9.17.2184 · Cited by 215
Sarin, A., Adams, D. H., & Henkart, P. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1693 · Cited by 195
Stephen, C. W., Helminen, P., & Lane, D. P. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0202 · Cited by 177
Degradation of transcription factors, c‐Jun and c‐Fos, by calpain
Hirai, S.-I., Kawasaki, H., Yaniv, M., & Suzuki, K. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80015-u · Cited by 163
Crook, T., & Vousden, K. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05487.x · Cited by 148
Self-citationScheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D., & Howley, P. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.5100-5105.1992 · Cited by 146
Post-translational modification of p53.
Meek, D. W. (1994) · PubMed · Cited by 139
Aloni-Grinstein, R., Schwartz, D., & Rotter, V. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07125.x · Cited by 114
Specific cleavage of transcription factors by the thiol protease, m-calpain
Watt, F., & Molloy, P. L. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.22.5092 · Cited by 101
Figueiredo‐Pereira, M. E., Banik, N. L., & Wilk, S. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62051989.x · Cited by 91
Bártek, J., Bártková, J., Lukáš, J., Stašková, Z., Vojtěšek, B., & Lane, D. P. (1993) · The Journal of Pathology · doi:10.1002/path.1711690106 · Cited by 90
Es, H., Picksley, S. M., & Kh, V. (1994) · PubMed · Cited by 88
Regulation of p53 protein expression in human breast cancer cell lines
Vojtěšek, B., & Lane, D. P. (1993) · Journal of Cell Science · doi:10.1242/jcs.105.3.607 · Cited by 84
Expression of RB and p53 proteins in HPV‐positive and HPV‐negative cervical carcinoma cell lines
Wrede, C. D., TIDY, J. A., Crook, T., Lane, D. P., & Vousden, K. H. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040302 · Cited by 84
Self-citationExpression of the normal p53 gene induces differentiation of K562 cells.
Feinstein, E., Gale, R. P., Reed, J., & Canaani, E. (1992) · PubMed · Cited by 83
Legros, Y., Meyer, A., Ory, K., & Soussi, T. (1994) · PubMed · Cited by 76
Marston, N., Crook, T., & Vousden, K. H. (1994) · PubMed · Cited by 69
Self-citationYonish-Rouach, E., Deguin, V., Zaitchouk, T., Breugnot, C., Mishal, Z., Jenkins, J. R., & May, E. (1995) · PubMed · Cited by 67
Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6.
Marston, N., Jenkins, J. R., & Vousden, K. H. (1995) · PubMed · Cited by 47
Self-citationSibbet, G. J., & Campo, M. S. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-11-2699 · Cited by 39
Oncogenes and cell proliferation
Marshall, C., & Wyllie, A. H. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)90002-7 · Cited by 30
Cited by
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationGOLL, D. E., THOMPSON, V. F., LI, H., WEI, W., & CONG, J. (2003) · Physiological Reviews · doi:10.1152/physrev.00029.2002 · Cited by 2,829
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
The p53–Mdm2 module and the ubiquitin system
Michael, D., & Oren, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00099-8 · Cited by 765
Metadata
- Authors
- Kubbutat, M. H. G., & Vousden, K. H.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1997-01-01
- Volume
- 17
- Issue
- 1
- Pages
- 460-468
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2169681364
- Cited by
- 307
- References
- 65
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.